Leslie Levin

1.6k total citations
30 papers, 1.0k citations indexed

About

Leslie Levin is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leslie Levin has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 7 papers in Economics and Econometrics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leslie Levin's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Healthcare cost, quality, practices (4 papers). Leslie Levin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Healthcare cost, quality, practices (4 papers). Leslie Levin collaborates with scholars based in Canada, United States and United Kingdom. Leslie Levin's co-authors include W M Hryniuk, Ron Goeree, Maurice Hirst, Vânia Costa, Harry C. Triandis, Craig C. Earle, Robert Fowler, Russell Goldman, Mary Jane Esplen and John J. You and has published in prestigious journals such as The Lancet, Journal of Personality and Social Psychology and Journal of Clinical Oncology.

In The Last Decade

Leslie Levin

29 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Levin Canada 16 251 244 238 174 155 30 1.0k
Manuel Rodrigues France 20 611 2.4× 108 0.4× 148 0.6× 76 0.4× 204 1.3× 123 1.4k
Maysa Al‐Hussaini Jordan 21 363 1.4× 217 0.9× 199 0.8× 227 1.3× 61 0.4× 173 1.9k
M. Stead United Kingdom 15 732 2.9× 120 0.5× 242 1.0× 121 0.7× 210 1.4× 17 1.3k
Hannu Halila Finland 16 228 0.9× 273 1.1× 204 0.9× 171 1.0× 258 1.7× 44 1.0k
Kristin Anderson United States 13 400 1.6× 55 0.2× 131 0.6× 108 0.6× 71 0.5× 17 1.3k
Deborah Cragun United States 23 335 1.3× 80 0.3× 284 1.2× 68 0.4× 212 1.4× 89 1.8k
Merry Jennifer Markham United States 20 420 1.7× 100 0.4× 246 1.0× 120 0.7× 304 2.0× 103 1.3k
Kristy Ward United States 19 424 1.7× 176 0.7× 114 0.5× 119 0.7× 86 0.6× 48 1.2k
Petronella B. Ottevanger Netherlands 30 1.2k 4.9× 485 2.0× 567 2.4× 273 1.6× 300 1.9× 129 2.5k
Melissa K. Frey United States 25 513 2.0× 455 1.9× 179 0.8× 296 1.7× 53 0.3× 147 1.7k

Countries citing papers authored by Leslie Levin

Since Specialization
Citations

This map shows the geographic impact of Leslie Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Levin more than expected).

Fields of papers citing papers by Leslie Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Levin. The network helps show where Leslie Levin may publish in the future.

Co-authorship network of co-authors of Leslie Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Levin. A scholar is included among the top collaborators of Leslie Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Levin. Leslie Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levin, Leslie, Murray Sheldon, Naomi Aronson, et al.. (2024). Early technology review: towards an expedited pathway. International Journal of Technology Assessment in Health Care. 40(1). e13–e13. 4 indexed citations
2.
Costa, Vânia, Craig C. Earle, Mary Jane Esplen, et al.. (2016). The determinants of home and nursing home death: a systematic review and meta-analysis. BMC Palliative Care. 15(1). 8–8. 132 indexed citations
3.
Levin, Leslie. (2015). EARLY EVALUATION OF NEW HEALTH TECHNOLOGIES: THE CASE FOR PREMARKET STUDIES THAT HARMONIZE REGULATORY AND COVERAGE PERSPECTIVES. International Journal of Technology Assessment in Health Care. 31(4). 207–209. 9 indexed citations
4.
Sikich, Nancy, Vânia Costa, K Kaulback, et al.. (2014). Health Care for People Approaching the End of Life: An Evidentiary Framework.. PubMed. 14(14). 1–45. 16 indexed citations
5.
Whelan, J. Paul, James M. Bowen, Natasha Burke, et al.. (2013). A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Canadian Urological Association Journal. 7(9-10). 335–335. 17 indexed citations
6.
Levin, Leslie, Murray Krahn, R Goeree, et al.. (2013). Excite – A New Collaborative Model Of Pre-Market Evaluation Of Health Technologies. Value in Health. 16(3). A264–A264. 1 indexed citations
7.
Sehatzadeh, S, K Kaulback, & Leslie Levin. (2012). Metal-on-metal hip resurfacing arthroplasty: an analysis of safety and revision rates.. PubMed. 12(19). 1–63. 15 indexed citations
8.
9.
Levin, Leslie, et al.. (2011). Coverage with evidence development: The Ontario experience. International Journal of Technology Assessment in Health Care. 27(2). 159–168. 28 indexed citations
10.
Whicher, Danielle, Kalipso Chalkidou, Irfan A. Dhalla, Leslie Levin, & Sean Tunis. (2009). Comparative Effectiveness Research in Ontario, Canada: Producing Relevant and Timely Information for Health Care Decision Makers. Milbank Quarterly. 87(3). 585–606. 10 indexed citations
11.
Levin, Leslie, et al.. (2007). Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. International Journal of Technology Assessment in Health Care. 23(3). 299–309. 37 indexed citations
12.
Goeree, Ron & Leslie Levin. (2006). Building Bridges Between Academic Research and Policy Formulation. PharmacoEconomics. 24(11). 1143–1156. 38 indexed citations
13.
Levin, Leslie & Susan J. Behrens. (2003). From Swoosh to Swoon: Linguistic Analysis of Nike's Changing Image. Business Communication Quarterly. 66(3). 52–65. 11 indexed citations
14.
Tonkin, Katia, Leslie Levin, & John Powe. (1994). Neither toxicity nor dose intensity of carboplatin is affected by glomerular filtration rate versus body surface area dose calculation in gynecologic malignancy. International Journal of Gynecological Cancer. 4(5). 315–319. 4 indexed citations
15.
Casson, Alan G., D. McCormack, Ian Craig, Richard Inculet, & Leslie Levin. (1993). A Persistent Pulmonary Lesion following Chemotherapy for Metastatic Choriocarcinoma. CHEST Journal. 103(1). 269–270. 6 indexed citations
16.
Levin, Leslie, Birthe Lund, & A. Peter M. Heintz. (1993). An overview of multi-variate analyses of prognostic variables with special reference to the role of cytoreductive surgery. Annals of Oncology. 4. S23–S29. 23 indexed citations
17.
Rusthoven, James J., Leslie Levin, J. Mazurka, et al.. (1991). Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 83(23). 1748–1753. 23 indexed citations
18.
Levin, Leslie, et al.. (1990). Postprandial Levels of Prolactin and Gut Hormones in Breast Cancer Patients: Association With Stage of Disease, but Not Dietary Fat. JNCI Journal of the National Cancer Institute. 82(1). 22–29. 7 indexed citations
19.
OʼConnell, G., Wendy Shelley, J. Carmichael, et al.. (1987). High-dose-intensity regimen of weekly doxorubicin and cisplatin in the treatment of patients with stage III and IV epithelial ovarian carcinoma.. PubMed. 71(5). 455–8. 3 indexed citations
20.
Hirst, Maurice, et al.. (1984). OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDE. The Lancet. 323(8370). 186–188. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Rodrigues Breakdown of academic impact, for papers by Maysa Al‐Hussaini Breakdown of academic impact, for papers by M. Stead Breakdown of academic impact, for papers by Hannu Halila Breakdown of academic impact, for papers by Kristin Anderson Breakdown of academic impact, for papers by Deborah Cragun Breakdown of academic impact, for papers by Merry Jennifer Markham Breakdown of academic impact, for papers by Kristy Ward Breakdown of academic impact, for papers by Petronella B. Ottevanger Breakdown of academic impact, for papers by Melissa K. Frey
Rankless by CCL
2026